SHIRLEY, N.Y., May 6, 2011 /PRNewswire/ — American
Regent announced today that it had resumed the shipment of its
multisource injectable products on May 5, 2011.  Release of
products is being prioritized and American Regent is working
closely with the FDA Drug Shortage Staff to ensure that supplies of
critically needed medications are available for patient care.

Please Note: Products have been shipped and are available from
your local Wholesaler or Distributor.

In addition to Venofer® (iron sucrose injection, USP), the
following products have been released and shipped:Atropine Sulfate
Injection, USPCaffeine Citrate Injection, USPChromic Chloride
Injection, USPConcentrated Zinc Sulfate Injection, USPDehydrated
Alcohol Injection, USPDopamine HCL Injection, USPDroperidol
Injection, USPGlycopyrrolate Injection, USPHydroxyzine HCL
Injection, USPIron Dextran Injection, USP
(Dexferrum®)L-Cysteine HCL Injection, USPMultitrace® -4
(Trace Elements Injection 4, USP)Multitrace® -4 Concentrate
(Trace Elements Injection 4, USP – Concentrate)Multitrace® -5
Concentrate (Trace Elements Injection 5, USP –
Concentrate)Neostigmine Methylsulfate Injection, USP
 Nitroglycerin Injection, USPPapaverine HCL Injection,
USPPhenylephrine HCL Injection, USPPotassium Phosphates Injection,
USPSodium Phosphates Injection, USPAmerican Regent can confirm that
these products were manufactured in accordance with cGMP and
quality requirements and that they meet all USP and other internal
monograph and quality release specifications. American Regent is
confident in the integrity and quality of these injectable
products.

Visit our website at www.americanregent.com
for daily updates on product releases and availability or
contact our Customer Service Department at: 1-800-645-1706. We
apologize for any inconvenience this temporary suspension of
manufacturing and distribution ha

‘/>”/>

SOURCE